$CODX News

Last published 1d ago

1d agoMI CODX VIVK247marketnews Editorial Watchlist November 10, 2026GlobeNewswire$KBLB, $MI, $CODX, and $VIVK are on this morning's watchlist
1d agoCODXCo-Diagnostics, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 7.01 Item 9.01
1d agoCODXCo-Diagnostics Reports Third Quarter 2026 Financial ResultsPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the...
1w agoCODXCo-Diagnostics Announces Third Quarter 2026 Earnings Release Date and WebcastPR NewswireSALT LAKE CITY, Oct. 29, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ:CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of
1w agoCODXCo-Diagnostics' Joint Venture CoSara Diagnostics Announces Publication of Peer-Reviewed HPV Screening Study Using CoSara's SARAGENE® TestPR NewswireFollow-Up Biopsies Identified High-Grade Lesions or Cervical Cancer in 12 of 20 HPV-Positive Women, Including a Cohort with Predominantly Negative Cytology ResultsCoSara to Exhibit at MICROCON 2026, the Annual Congress
2w agoCODXCo-Diagnostics' Joint Venture CoSara Diagnostics Completes Clinical Study and Regulatory Submission for Point-of-Care Tuberculosis Test, Sets Stage for Commercial Launch in IndiaPR NewswireCDSCO Clearance and Commercial Launch in India Anticipated Before Year-End 2026Study Demonstrated 97.3% Sensitivity and 96.0% SpecificityConsistent Performance Across Three Test BatchesIntegrated Mobile and Cloud
3w agoCODXCo-Diagnostics' Joint Venture CoMira Diagnostics Invited by Saudi Ministry to Participate in Strategic Manufacturing ForumPR NewswireParticipation in NUWATIN 2026 to Support Advancement of Strategic Manufacturing, Technology Transfer, and Industrial Localization Initiatives Under Saudi Vision 2030Invitation Follows Execution of Manufacturing Facility
3w agoCODXCo-Diagnostics Highlights PCR Platform Capabilities for Potential Plague DetectionPR NewswireExisting Sputum Sample-Preparation Technology Provides Potential Foundation for Plague DiagnosticsDraws on Rapid-Response Experience with COVID-19, Mpox and Ebola Supported by Expanded Manufacturing InfrastructureSALT
1mo agoCODXCo-Diagnostics Announces First Full Vector Smart® Laboratory Installation for Native American TribePR NewswireUte Indian Tribe Mosquito Abatement Department to bring PCR-based mosquito surveillance testing in houseSALT LAKE CITY, Oct. 8, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ:CODX) ("Co-Dx" or "the
1mo agoCODXCo-Diagnostics Highlights Vector Smart® Momentum Following New Federal Initiative on Vector-Borne DiseasePR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
1mo agoCODXCo-Diagnostics to Showcase Co-Dx PCR Platform* and MTB Test at WHX Labs Johannesburg, Highlight Ebola Assay DevelopmentPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
1mo agoCODXCo-Diagnostics to Participate in Global Health Events During UN General Assembly WeekPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
1mo agoCODXCo-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak InnovationPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
1mo agoCODXCo-Diagnostics to Participate in Joint WHO/Unitaid/UNAIDS Annual Consultation Meeting on September 17-18, 2026PR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
1mo agoCODXCo-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with EbolaPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
1mo agoCODXCo-Diagnostics to Hold Press ConferencePR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
2mo agoCODXCo-Diagnostics Completes New Vector Smart® Laboratory Installations Amid Rising Dengue Activity in FloridaPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
2mo agoCODXCo-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in IndiaPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
2mo agoCODXCo-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF BasePR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
2mo agoCODXCo-Diagnostics Participates in Medical Devices and Innovations Roundtable Media EventPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
3mo agoCODXCo-Diagnostics Reports Second Quarter 2026 Financial ResultsPR NewswireAdvancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing ExpansionStrengthening Integrated Co-Dx PCR Platform Through Scientific Innovation, Cloud Connectivity and AI-Enabled
3mo agoCODXCo-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care TestPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
3mo agoCODXCo-Diagnostics Announces Second Quarter 2026 Earnings Release Date and WebcastPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
3mo agoCODXCo-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical StudiesPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
3mo agoCODXCo-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR PlatformPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
3mo agoCODXCo-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific OfficerPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
4mo agoCODXCo-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, ThailandPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
4mo agoCODXCo-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care TestPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
4mo agoCODXCo-Diagnostics Vector Smart® Division Expands Footprint to 21 StatesPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
4mo agoCODXCo-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing LinePR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
5mo agoCODXCo-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor AgreementPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
5mo agoCODXCo-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform CapabilitiesPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
5mo agoCODXCo-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSaraPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
5mo agoCODXCo-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq RulesPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx", or the "Company"), a molecular diagnostics company with a unique, patented platform for the development ...
5mo agoCODXCo-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak AlertPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
6mo agoCODXCo-Diagnostics Reports First Quarter 2026 Financial ResultsPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx," or "the Company"), a molecular diagnostics company with a unique, patented platform for the development ...
6mo agoCODXCo-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial CityPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
6mo agoCODXCo-Diagnostics Announces First Quarter 2026 Earnings Release Date and WebcastPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
6mo agoCODXCo-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.PR NewswireCo-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of...
7mo agoCODXCo-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, GermanyPR NewswireCo-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of...
7mo agoCODXCo-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC UtahPR NewswireCo-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of...
7mo agoCODXCo-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial CityPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
7mo agoCODXCo-Diagnostics Reports Full Year 2025 Financial ResultsPR NewswireCo-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Diagnostics," "Co-Dx," or "the Company"), a molecular diagnostics company with a unique, patented platform...
7mo agoCODXCo-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health OrganizationPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
7mo agoCODXCo-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South AsiaPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
7mo agoCODXCo-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and WebcastPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
8mo agoCODXCo-Diagnostics to Present at Medical Korea 2026PR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
8mo agoCODXCo-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform TechnologiesPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
8mo agoCODXCo-Diagnostics Regains Compliance with Nasdaq Listing RequirementsPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...
10mo agoCODXCo-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor RelationshipsPR NewswireCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development...